OCUL short interest
Ocular Therapeutix Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 29,412,673 |
|---|---|
| Change vs prior report | -520,467 (-1.7%) |
| Change over six months | +16.8% |
| Days to cover | 7.25 (sector: 3.78) |
| Average daily volume | 4,057,160 |
| Rank in Healthcare | #232 of 922 by days to cover |
OCUL short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 29,412,673 | -1.7% | 7.25 | 4,057,160 |
| 2026-09-15 | 29,933,140 | +6.7% | 14.19 | 2,109,453 |
| 2026-08-31 | 28,055,522 | -1.6% | 8.96 | 3,130,920 |
| 2026-08-14 | 28,515,335 | +6.7% | 12.68 | 2,248,116 |
| 2026-07-31 | 26,735,397 | -1.1% | 13.49 | 1,981,296 |
| 2026-07-15 | 27,027,521 | +1.2% | 13.07 | 2,067,987 |
| 2026-06-30 | 26,695,136 | +0.9% | 6.56 | 4,070,456 |
| 2026-06-15 | 26,456,015 | +5.5% | 11.85 | 2,233,292 |
| 2026-05-29 | 25,086,045 | +1.2% | 9.04 | 2,774,994 |
| 2026-05-15 | 24,777,685 | -0.1% | 8.49 | 2,917,209 |
| 2026-04-30 | 24,793,045 | +1.1% | 8.57 | 2,894,022 |
| 2026-04-15 | 24,526,963 | -2.6% | 6.99 | 3,509,392 |
| 2026-03-31 | 25,192,853 | +6.4% | 7.20 | 3,496,818 |
| 2026-03-13 | 23,683,101 | +34.2% | 3.56 | 6,660,775 |
| 2026-02-27 | 17,648,381 | +20.0% | 1.44 | 12,294,841 |
| 2026-02-13 | 14,706,215 | +27.8% | 2.98 | 4,940,376 |
| 2026-01-30 | 11,506,830 | -10.0% | 2.70 | 4,255,250 |
| 2026-01-15 | 12,790,655 | +3.6% | 2.21 | 5,782,461 |
| 2025-12-31 | 12,345,939 | +16.5% | 4.32 | 2,859,553 |
| 2025-12-15 | 10,593,646 | -8.9% | 2.33 | 4,537,813 |
| 2025-11-28 | 11,633,800 | -11.7% | 3.80 | 3,059,476 |
| 2025-11-14 | 13,173,573 | -4.4% | 6.89 | 1,912,802 |
| 2025-10-31 | 13,773,939 | +1.4% | 6.46 | 2,132,143 |
| 2025-10-15 | 13,585,178 | +0.2% | 3.05 | 4,460,874 |
| 2025-09-30 | 13,557,599 | -11.3% | 5.00 | 2,712,846 |
import finzdata as yf
yf.Ticker("OCUL").short_interest # every report since 2017
yf.Client().short_interest(["OCUL"], start="2018-01-01")Healthcare short interest · OCUL price history · Who owns OCUL · All short interest